Table 8.
Median Follow-Up of 10.5 yr by Survey (n=673) | estimated GFR <60 (n=228) | estimated GFR <45 (n=32) | ||
---|---|---|---|---|
OR (95% CI) | P Value | OR (95% CI) | P Value | |
Unadjusted | ||||
Nephron number, per 100,000 | 0.92 (0.88 to 0.96) | <0.0001 | 0.85 (0.76 to 0.95) | 0.003 |
Nephron number <5th percentile | 2.49 (1.36 to 4.55) | 0.003 | 5.29 (2.23 to 12.6) | 0.0002 |
Nephron number <10th percentile | 2.72 (1.69 to 4.36) | <0.0001 | 5.06 (2.37 to 10.8) | <0.0001 |
%GSG, per SD | 1.35 (1.16 to 1.58) | 0.0001 | 1.31 (1.01 to 1.70) | 0.04 |
IFTA, per 5% | 3.94 (1.47 to 10.6) | 0.007 | 1.79 (1.03 to 3.09) | 0.04 |
IFTA foci density, per SD | 1.19 (1.03 to 1.36) | 0.01 | 1.15 (0.90 to 1.47) | 0.27 |
Adjusted for nephrosclerosis measuresb | ||||
Nephron number, per 100,000 | 0.92 (0.89 to 0.97) | 0.0004 | 0.86 (0.77 to 0.96) | 0.008 |
Nephron number <5th percentile | 2.38 (1.28 to 4.42) | 0.006 | 4.90 (1.99 to 12.1) | 0.0006 |
Nephron number <10th percentile | 2.68 (1.65 to 4.36) | <0.0001 | 4.91 (2.22 to 10.8) | <0.0001 |
Further adjusted for glomerular volume | ||||
Nephron number, per 100,000 | 0.91 (0.86 to 0.95) | <0.0001 | 0.88 (0.78 to 0.99) | 0.03 |
Nephron number <5th percentile | 2.55 (1.35 to 4.85) | 0.004 | 4.07 (1.56 to 10.6) | 0.004 |
Nephron number <10th percentile | 2.93 (1.77 to 4.87) | <0.0001 | 4.29 (1.86 to 9.86) | 0.0006 |
Further adjusted for clinical characteristicsc | ||||
Nephron number, per 100,000 | 0.94 (0.89 to 0.99) | 0.04 | 0.92 (0.81 to 1.04) | 0.19 |
Nephron number <5th percentile | 2.61 (1.26 to 5.38) | 0.009 | 4.00 (1.44 to 11.1) | 0.008 |
Nephron number <10th percentile | 3.37 (1.89 to 5.99) | <0.0001 | 4.68 (1.92 to 11.4) | 0.0007 |
OR, odds ratio; CI, confidence interval; GSG, globally sclerotic glomerular; IFTA, interstitial fibrosis and tubular atrophy.
%GSG, %IFTA and interstitial fibrosis and tubular atrophy foci density.
Age, follow-up time, sex, and baseline GFR.